Rearrangements of MYC or ABL proto-oncogenes lead to deregulated expression of key-regulators of cell cycle and cell survival, thereby constituting important drivers of blood cancer. This evidence concerns the gene ABL1 and hematopoietic and lymphoid system neoplasm.